Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/24/2026 | Q1 | $346.6M | -- | -- | $0.96 | -- |
| 12/16/2025 | Q4 | $310.6M | $327.5M | $0.55 | $0.70 | -$0.15 |
| 09/23/2025 | Q3 | $291.8M | $303.7M | $0.70 | $0.70 | $0.00 |
| 06/24/2025 | Q2 | $301.4M | $317.9M | $0.08 | $0.84 | -$0.77 |
| 03/25/2025 | Q1 | $289.1M | $304.5M | $0.79 | $0.71 | $0.09 |
| 12/17/2024 | Q4 | $273.8M | $274M | $0.56 | $0.52 | $0.05 |
| 09/24/2024 | Q3 | $296.1M | $257.3M | $0.48 | $0.71 | -$0.23 |
| 06/25/2024 | Q2 | $352.8M | $318.8M | -$0.64 | $0.88 | -$1.52 |
| 03/20/2024 | Q1 | $323.4M | $316.8M | $0.44 | $0.69 | -$0.26 |
| 12/19/2023 | Q4 | $297.3M | $298.2M | $0.49 | $0.61 | -$0.12 |
| 09/27/2023 | Q3 | -- | $311.9M | $1.93 | -- | -- |
| 06/28/2023 | Q2 | -- | $368.8M | $2.63 | -- | -- |
| 03/22/2023 | Q1 | -- | $346.3M | $0.94 | -- | -- |
| 12/21/2022 | Q4 | -- | $1.2B | $0.33 | -- | -- |
| 09/29/2022 | Q3 | -- | $1.4B | $1.30 | -- | -- |
| 06/22/2022 | Q2 | -- | $1.5B | $1.61 | -- | -- |
| 03/22/2022 | Q1 | -- | $1.4B | $1.11 | -- | -- |
| 12/16/2021 | Q4 | -- | $1.2B | $2.15 | -- | -- |
| 09/29/2021 | Q3 | -- | $1.1B | $2.55 | -- | -- |
| 06/24/2021 | Q2 | -- | $978.3M | $2.15 | -- | -- |
| 03/24/2021 | Q1 | -- | $759.1M | $1.27 | -- | -- |
| 12/17/2020 | Q4 | -- | $731.1M | -$1.40 | -- | -- |
| 09/23/2020 | Q3 | -- | $702.9M | $11.22 | -- | -- |
| 06/25/2020 | Q2 | -- | $611.6M | $0.29 | -- | -- |
| 03/26/2020 | Q1 | -- | $764M | $0.27 | -- | -- |
| 12/17/2019 | Q4 | -- | $827.6M | $0.93 | -- | -- |
| 09/25/2019 | Q3 | -- | $855.9M | -$0.09 | -- | -- |
| 06/26/2019 | Q2 | -- | $938.8M | $0.66 | -- | -- |
| 03/20/2019 | Q1 | -- | $874.4M | $0.46 | -- | -- |
| 12/18/2018 | Q4 | -- | $958.2M | $0.57 | -- | -- |
| 09/26/2018 | Q3 | -- | $988.1M | $0.91 | -- | -- |
| 06/28/2018 | Q2 | -- | $1B | $0.50 | -- | -- |
| 03/29/2018 | Q1 | -- | $841.7M | $1.27 | -- | -- |
| 12/19/2017 | Q4 | -- | $871.3M | $0.62 | -- | -- |
| 09/27/2017 | Q3 | -- | $848.2M | $0.70 | -- | -- |
| 06/29/2017 | Q2 | -- | $845.3M | $0.87 | -- | -- |
| 03/30/2017 | Q1 | -- | $703.4M | $0.55 | -- | -- |
| 12/20/2016 | Q4 | -- | $727.8M | $0.72 | -- | -- |
| 09/28/2016 | Q3 | -- | $737.5M | $1.02 | -- | -- |
| 06/29/2016 | Q2 | -- | $714.7M | $0.91 | -- | -- |
| 03/23/2016 | Q1 | -- | $647.1M | $0.47 | -- | -- |
Worthington Enterprises, Inc. reported $327.5M worth of top line sales in its most recent quarter.
Worthington Enterprises, Inc. announced earnings per share of $0.55 which represents a miss of analyst forecast a $0.70 per share.
Worthington Enterprises, Inc. reported $84.6M that represents $1.70 per share over the last quarter.
Worthington Enterprises, Inc.'s earnings are forecast to grow from $1.92 per share to $2.85 per share next year representing an increase of 81.32%.
Worthington Enterprises, Inc.'s next earnings date is March 24, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.